State of Alaska, Department of Revenue

Position in TGTX — Tg Therapeutics, Inc.

CIK 1370102 JUNEAU, AK

Position in TGTX

as of Mar 31, 2026 · filed Apr 20, 2026 Compact

Position Value

$2,868,314

+$238,924 QoQ

Shares Held

86,343

-2.1% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

State of Alaska, Department of Revenue holds $92,461,767 across 47 Biotechnology names. TGTX ranks #8 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	33,180	$14,816,196
2	REGN	Regeneron Pharmaceuticals, Inc.	18,363	$14,187,988
3	HALO	Halozyme Therapeutics, Inc.	157,004	$10,147,168
4	JAZZ	Jazz Pharmaceuticals plc	42,042	$7,948,040
5	KRYS	Krystal Biotech, Inc.	17,484	$4,516,465
6	PTGX	Protagonist Therapeutics, Inc	37,147	$3,915,293
7	PTCT	Ptc Therapeutics, Inc.	44,098	$3,004,396
8	TGTX	Tg Therapeutics, Inc. This page	86,343	$2,868,314

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,868,314	86,343	-2.1%	Shares	Sole	2026-04-20
2025-12-31	$2,629,390	88,205	+29.2%	Shares	Sole	2026-01-23
2025-09-30	$2,466,362	68,273	-15.5%	Shares	Sole	2025-10-24
2025-06-30	$2,907,379	80,783	+9.2%	Shares	Sole	2025-07-16
2025-03-31	$2,916,085	73,956	-2.5%	Shares	Sole	2025-04-21
2024-12-31	$2,283,265	75,856	-0.4%	Shares	Sole	2025-01-27
2024-09-30	$1,780,680	76,130	—	Shares	Sole	2024-10-24
No filing history on record for this holder in this stock.